Nulife Dialysis Inc. in Opa Locka, Florida - Dialysis Center

Nulife Dialysis Inc. is a medicare approved dialysis facility center in Opa Locka, Florida and it has 13 dialysis stations. It is located in Miami-dade county at 4805 Nw 183rd Street, Opa Locka, FL, 33055. You can reach out to the office of Nulife Dialysis Inc. at (305) 952-4925. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. Nulife Dialysis Inc. has the following ownership type - Profit. It was first certified by medicare in May, 2016. The medicare id for this facility is 682608 and it accepts patients under medicare ESRD program.

Name	Nulife Dialysis Inc.
Location	4805 Nw 183rd Street, Opa Locka, Florida
No. of Dialysis Stations	13
Medicare ID	682608
Managed By	Independent
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Nulife Dialysis Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1801263009
Doing Business As	Nulife Dialysis, Inc.
Address	4805 Nw 183rd St Miami Gardens, Florida, 33055
Phone Number	(305) 952-4925

Dialysis patients with Hemoglobin data

7

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	23
  Adult patient months included in Kt/V greater than or equal to 1.2	126
  Percentage of adult patients getting regular hemodialysis at the center	80
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Nulife Dialysis Inc. with elevated calcium levels.

Patients with hypercalcemia	23
Hypercalcemia patient months	126
Patients with Serumphosphor	25
Patients with Serumphosphor less than 3.5 mg/dL	19
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	28
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	21
Patients with Serumphosphor from 5.6 to 7 mg/dL	23
Patients with Serumphosphor greater than 7 mg/dL	9

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	27
Patient months included in arterial venous fistula and catheter summaries	107
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	43
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	33

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) Year	January, 2016 - December, 2016
Patients in facility's Hospitalization Summary	10
Hospitalization Rate in facility	(Not Available)
Hospitalization Rate: Upper Confidence Limit
Hospitalization Rate: Lower Confidence Limit